
Arthur S. Leonard
Examiner (ID: 12301, Phone: (571)270-3073 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1631, 1633 |
| Total Applications | 655 |
| Issued Applications | 267 |
| Pending Applications | 112 |
| Abandoned Applications | 289 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12002130
[patent_doc_number] => 20170306284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'BUBBLE JETTING CHIP, LOCAL ABLATION DEVICE AND LOCAL ABLATION METHOD, AND INJECTION DEVICE AND INJECTION METHOD'
[patent_app_type] => utility
[patent_app_number] => 15/512618
[patent_app_country] => US
[patent_app_date] => 2015-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7920
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512618
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/512618 | Bubble-jetting chip, localized ablation device and localized ablation method, and injection device and injection method | Sep 28, 2015 | Issued |
Array
(
[id] => 10729937
[patent_doc_number] => 20160076086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'NANO-PLASMONIC MOLECULAR PROBES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/861353
[patent_app_country] => US
[patent_app_date] => 2015-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 23426
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14861353
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/861353 | Nano-plasmonic molecular probes and methods of use | Sep 21, 2015 | Issued |
Array
(
[id] => 11886855
[patent_doc_number] => 09757402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-12
[patent_title] => 'Method for measuring cell-to-cell transmission of α-synuclein aggregates using bimolecular fluorescence complementation system and method for screening a substance for preventing or treating neurodegenerative disease using the same'
[patent_app_type] => utility
[patent_app_number] => 14/855645
[patent_app_country] => US
[patent_app_date] => 2015-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 122
[patent_no_of_words] => 17927
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14855645
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/855645 | Method for measuring cell-to-cell transmission of α-synuclein aggregates using bimolecular fluorescence complementation system and method for screening a substance for preventing or treating neurodegenerative disease using the same | Sep 15, 2015 | Issued |
Array
(
[id] => 10715670
[patent_doc_number] => 20160061818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'ISLET1 (ISL1) And Hearing Loss'
[patent_app_type] => utility
[patent_app_number] => 14/853527
[patent_app_country] => US
[patent_app_date] => 2015-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16301
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14853527
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/853527 | Islet1 (ISl1) and hearing loss | Sep 13, 2015 | Issued |
Array
(
[id] => 16025965
[patent_doc_number] => 10675382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Schwann cells and method for preparing same
[patent_app_type] => utility
[patent_app_number] => 15/509912
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 28
[patent_no_of_words] => 10631
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15509912
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/509912 | Schwann cells and method for preparing same | Sep 10, 2015 | Issued |
Array
(
[id] => 13127787
[patent_doc_number] => 10081816
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-09-25
[patent_title] => Mechanical transfection devices and methods
[patent_app_type] => utility
[patent_app_number] => 14/852433
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 8471
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14852433
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/852433 | Mechanical transfection devices and methods | Sep 10, 2015 | Issued |
Array
(
[id] => 16784909
[patent_doc_number] => 10987308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Therapeutic nanoparticles and related compositions, methods and systems
[patent_app_type] => utility
[patent_app_number] => 14/844828
[patent_app_country] => US
[patent_app_date] => 2015-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20231
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14844828
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/844828 | Therapeutic nanoparticles and related compositions, methods and systems | Sep 2, 2015 | Issued |
Array
(
[id] => 11971494
[patent_doc_number] => 20170275648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'NOVEL CAS9 PROTEINS AND GUIDING FEATURES FOR DNA TARGETING AND GENOME EDITING'
[patent_app_type] => utility
[patent_app_number] => 15/507176
[patent_app_country] => US
[patent_app_date] => 2015-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 22921
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507176
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/507176 | Cas9 proteins and guiding features for DNA targeting and genome editing | Aug 26, 2015 | Issued |
Array
(
[id] => 11864823
[patent_doc_number] => 20170232109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'PROTEIN/OLIGONUCLEOTIDE CORE-SHELL NANOPARTICLE THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 15/502955
[patent_app_country] => US
[patent_app_date] => 2015-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 28293
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502955
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/502955 | Protein/oligonucleotide core-shell nanoparticle therapeutics | Aug 18, 2015 | Issued |
Array
(
[id] => 10756156
[patent_doc_number] => 20160102308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-14
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR OXIDATIVE STRESS AND RETINITIS PIGMENTOSA'
[patent_app_type] => utility
[patent_app_number] => 14/826674
[patent_app_country] => US
[patent_app_date] => 2015-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 30152
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14826674
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/826674 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR OXIDATIVE STRESS AND RETINITIS PIGMENTOSA | Aug 13, 2015 | Abandoned |
Array
(
[id] => 14246207
[patent_doc_number] => 10273295
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Chimeric antigen receptor specific for SSEA4 antigen
[patent_app_type] => utility
[patent_app_number] => 15/504933
[patent_app_country] => US
[patent_app_date] => 2015-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10392
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15504933
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/504933 | Chimeric antigen receptor specific for SSEA4 antigen | Aug 11, 2015 | Issued |
Array
(
[id] => 11757506
[patent_doc_number] => 20170204374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'METHOD FOR EVALUATING QUALITY OF HUMAN MESENCHYMAL STEM CELL, AND MONOCLONAL ANTIBODY FOR USE IN SAID METHOD'
[patent_app_type] => utility
[patent_app_number] => 15/321679
[patent_app_country] => US
[patent_app_date] => 2015-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6235
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321679
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/321679 | METHOD FOR EVALUATING QUALITY OF HUMAN MESENCHYMAL STEM CELL, AND MONOCLONAL ANTIBODY FOR USE IN SAID METHOD | Jul 30, 2015 | Abandoned |
Array
(
[id] => 11836660
[patent_doc_number] => 20170218379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'COMPOSITIONS AND METHODS FOR SELF-REGULATED INDUCIBLE GENE EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 15/500591
[patent_app_country] => US
[patent_app_date] => 2015-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 31869
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15500591
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/500591 | Compositions and methods for self-regulated inducible gene expression | Jul 30, 2015 | Issued |
Array
(
[id] => 18215166
[patent_doc_number] => 11590078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Viral immunogenic compositions
[patent_app_type] => utility
[patent_app_number] => 14/812114
[patent_app_country] => US
[patent_app_date] => 2015-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6580
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14812114
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/812114 | Viral immunogenic compositions | Jul 28, 2015 | Issued |
Array
(
[id] => 12037853
[patent_doc_number] => 09816074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells'
[patent_app_type] => utility
[patent_app_number] => 14/807183
[patent_app_country] => US
[patent_app_date] => 2015-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 38
[patent_no_of_words] => 25535
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14807183
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/807183 | Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells | Jul 22, 2015 | Issued |
Array
(
[id] => 11886873
[patent_doc_number] => 09757420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-12
[patent_title] => 'Gene editing for HIV gene therapy'
[patent_app_type] => utility
[patent_app_number] => 14/807595
[patent_app_country] => US
[patent_app_date] => 2015-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 49
[patent_no_of_words] => 31386
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14807595
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/807595 | Gene editing for HIV gene therapy | Jul 22, 2015 | Issued |
Array
(
[id] => 10671145
[patent_doc_number] => 20160017290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'METHODS OF INCREASING INSULIN CONTENT IN CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/803270
[patent_app_country] => US
[patent_app_date] => 2015-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18753
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14803270
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/803270 | METHODS OF INCREASING INSULIN CONTENT IN CELLS | Jul 19, 2015 | Abandoned |
Array
(
[id] => 11963819
[patent_doc_number] => 20170267972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'PRODUCTION METHOD FOR PLURIPOTENT STEM CELLS HAVING ANTIGEN-SPECIFIC T CELL RECEPTOR GENE'
[patent_app_type] => utility
[patent_app_number] => 15/326968
[patent_app_country] => US
[patent_app_date] => 2015-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13309
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326968
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326968 | PRODUCTION METHOD FOR PLURIPOTENT STEM CELLS HAVING ANTIGEN-SPECIFIC T CELL RECEPTOR GENE | Jul 16, 2015 | Abandoned |
Array
(
[id] => 15666915
[patent_doc_number] => 10597678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Bis-alkoxyl amide alkyl cationic peptide lipids, synthesis method thereof, and application thereof
[patent_app_type] => utility
[patent_app_number] => 15/550472
[patent_app_country] => US
[patent_app_date] => 2015-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 9205
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550472
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550472 | Bis-alkoxyl amide alkyl cationic peptide lipids, synthesis method thereof, and application thereof | Jun 24, 2015 | Issued |
Array
(
[id] => 14852653
[patent_doc_number] => 10415040
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-17
[patent_title] => Nucleic acid amphiphiles and nanostructures
[patent_app_type] => utility
[patent_app_number] => 15/321644
[patent_app_country] => US
[patent_app_date] => 2015-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15416
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 250
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321644
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/321644 | Nucleic acid amphiphiles and nanostructures | Jun 21, 2015 | Issued |